N Terminal- pro Brain Natriuretic Peptide as a Biomarker for differentiating Cardiac and Pulmonary Disease in Term Neonates with Respiratory Distress

Conclusion: The term neonates with RD have an increase in plasma NT-pro BNP. NT-pro BNP is a very good useful test for identification of CHD in neonates with RD, in comparison to PD. Therefore, plasma NT- pro BNP can be used to differentiate between cardiac and pulmonary cause of RD.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research